Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Deciphera Pharmaceuticals, Inc.    DCPH

DECIPHERA PHARMACEUTICALS, INC.

(DCPH)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Upcoming events on DECIPHERA PHARMACEUTICALS,
10/28/19 | 11:30am Aacr-nci-eortc international conference - abstract number: b129
10/28/19 | 11:30am Aacr-nci-eortc international conference - abstract number: b055
10/29/19 | 11:30am Aacr-nci-eortc international conference - abstract number: c077
10/29/19 | 11:30am Aacr-nci-eortc international conference - abstract number: c087
Past events on DECIPHERA PHARMACEUTICALS,
10/02/19 | 09:30am Cantor Global Health Care Conference
09/30/19 | 08:45am European Society for Medical Oncology Congress - Abstract LBA87
08/13/19 | 08:00am Ripretinib INVICTUS Pivotal Phase 3 Clinical Study Results Call
08/02/19 | 07:00am Interim 2019 Earnings Release
Upcoming sector events for DECIPHERA PHARMACEUTICALS,
10/23/19 TONGHUA DONGBAO PHARMACEUTICAL CO., LTD. : Q3 2019 Earnings Release
10/23/19 | 02:00pm CHARLES RIVER LABORATORIES INTERNATIONAL, INC. : Society for Neuroscience Meeting
10/24/19 SHANGHAI RAAS BLOOD PRODUCTS CO., LTD. : Q3 2019 Earnings Release
10/24/19 | 04:30pm GILEAD SCIENCES, INC. : Q3 2019 Earnings Call
More events
Past sector events for DECIPHERA PHARMACEUTICALS,
10/17/19 | 01:14pm QIAGEN N.V. : American Society for Human Genetics Meeting
10/17/19 | 03:30pm QIAGEN N.V. : American Society for Human Genetics Meeting
10/22/19 | 08:00am GALAPAGOS NV : Extraordinary Shareholders Meeting
10/22/19 | 02:00pm CHARLES RIVER LABORATORIES INTERNATIONAL, INC. : Society for Neuroscience Meeting
Annual publications
Annual results201720182019 (e)2020 (e)2021 (e)
Sales
M $
Released
Forecast
Spread





25,6

9,61

59,1
Operating income
(EBITDA)
M $
Released
Forecast
Spread
-50,8
-45,6
-11%
-104


-173

-177

-236
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-50,9
-42,6
-20%
-104
-98,9
-5,3%

-176

-219

-222
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-50,3
-39,7
-27%
-99,9
-95,9
-4,1%

-172

-212

-216
Net income
M $
Released
Forecast
Spread
-50,3
-39,8
-26%
-99,9
-95,4
-4,6%

-172

-217

-214
EPS
 $
Released
Forecast
Spread
-2,99
-2,51
-19%
-2,82
-2,67
-5,5%

-4,15

-4,68

-4,07
Announcement Date03/28/201803/14/2019

Assessed data source
© 2019 S&P Global Market Intelligence
© 2019 Factset
Net sales (Year) - Rate of surprise
Operating profit (Year) - Rate of surprise
EPS (Year) - Rate of surprise